Systems Oncology

Systems Oncology believes that the discovery of innovative cancer drugs requires the exponential power of artificial intelligence to uncover deeper mechanistic insights into cancer biology. By leveraging advanced cognitive computing technologies, we can aggregate and mine diverse biomedical datasets to reveal new contextual vulnerabilities in cancer. Collaborating with top-tier universities, we exploit these vulnerabilities using cutting-edge agents. We then invest in the most promising experimental drugs to demonstrate their therapeutic potential. Finally, we partner with pharmaceutical companies to translate these innovative new drugs into the next breakthrough cancer treatments.Our multidisciplinary team includes world-class experts from fields such as mathematics, artificial intelligence, systems biology, and oncology, all guided by deep clinical development experience. Combining our expertise with our revolutionary approach enables us to discover and develop the next generation of cancer therapies with unprecedented speed and precision.